Novel N,N-dialkyl cyanocinnamic acids as monocarboxylate transporter 1 and 4 inhibitors

nork Jonnalagadda, Shirisha, Jonnalagadda, Sravan K., Ronayne, Conor T., Nelson, Grady L., Solano, Lucas N., Rumbley, Jon, Holy, Jon, Mereddy, Venkatram R., Drewes, Lester R.
Argitaratua izan da Oncotarget (2019)

Coumarin carboxylic acids as monocarboxylate transporter 1 inhibitors: In vitro and in vivo studies as potential anticancer agents

nork Gurrapu, Shirisha, Jonnalagadda, Sravan K., Alam, Mohammad A., Ronayne, Conor T., Nelson, Grady L., Solano, Lucas N., Lueth, Erica A., Drewes, Lester R., Mereddy, Venkatram R.
Argitaratua izan da Bioorg Med Chem Lett (2016)

Development of Novel Silyl Cyanocinnamic Acid Derivatives as Metabolic Plasticity Inhibitors for Cancer Treatment

nork Nelson, Grady L., Ronayne, Conor T., Solano, Lucas N., Jonnalagadda, Sravan K., Jonnalagadda, Shirisha, Rumbley, Jon, Holy, Jon, Rose-Hellekant, Teresa, Drewes, Lester R., Mereddy, Venkatram R.
Argitaratua izan da Sci Rep (2019)

Synthesis, in vitro, and in vivo evaluation of novel N-phenylindazolyl diarylureas as potential anti-cancer agents

nork Solano, Lucas N., Nelson, Grady L., Ronayne, Conor T., Jonnalagadda, Shirisha, Jonnalagadda, Sravan K., Kottke, Kaija, Chitren, Robert, Johnson, Joseph L., Pandey, Manoj K., Jonnalagadda, Subash C., Mereddy, Venkatram R.
Argitaratua izan da Sci Rep (2020)